MERIT MEDICAL SYSTEMS INC Operating Lease, Right-of-Use Asset, Amortization Expense
MERIT MEDICAL SYSTEMS INC (MMSI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $5.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-30
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $2.92M, a 5.14% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $2.85M, a 4.36% decline year-over-year.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $2.79M, a 6.44% decline year-over-year.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $2.93M, a 1.78% decline year-over-year.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $11.48M, a 4.51% decline from fiscal 2024.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $12.02M, a 6.33% increase from fiscal 2023.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for fiscal 2023 was $11.31M, a 8.78% increase from fiscal 2022.
- MERIT MEDICAL SYSTEMS INC operating lease, right-of-use asset, amortization expense for fiscal 2022 was $10.39M, a 11.30% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $5.78M 10-Q · filed 2026-07-30 | $8.57M derived: sum of 3 quarters · filed 2026-07-30 | $11.49M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $2.85M 10-Q · filed 2026-04-30 | $5.64M derived: sum of 2 quarters · filed 2026-04-30 | $8.57M derived: sum of 3 quarters · filed 2026-04-30 | $11.35M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.71M derived: sum of 2 quarters · filed 2026-02-24 | $8.50M derived: sum of 3 quarters · filed 2026-07-30 | $11.48M 10-K · filed 2026-02-24 |
| 2025-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.71M derived: sum of 2 quarters · filed 2026-07-30 | $8.69M 10-Q · filed 2025-10-30 | $11.67M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $5.77M 10-Q · filed 2026-07-30 | $8.75M derived: sum of 3 quarters · filed 2026-07-30 | $11.73M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $2.98M 10-Q · filed 2026-04-30 | $5.96M derived: sum of 2 quarters · filed 2026-04-30 | $8.94M derived: sum of 3 quarters · filed 2026-04-30 | $11.88M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.96M derived: sum of 2 quarters · filed 2026-02-24 | $8.90M derived: sum of 3 quarters · filed 2026-02-24 | $12.02M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.92M derived: sum of 2 quarters · filed 2025-10-30 | $9.04M 10-Q · filed 2025-10-30 | $11.73M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $6.06M 10-Q · filed 2025-07-30 | $8.75M derived: sum of 3 quarters · filed 2026-02-24 | $11.44M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $3.12M 10-Q · filed 2025-04-24 | $5.81M derived: sum of 2 quarters · filed 2026-02-24 | $8.49M derived: sum of 3 quarters · filed 2026-02-24 | $11.77M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.37M derived: sum of 2 quarters · filed 2026-02-24 | $8.64M derived: sum of 3 quarters · filed 2026-02-24 | $11.31M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $5.96M derived: sum of 2 quarters · filed 2024-10-30 | $8.62M 10-Q · filed 2024-10-30 | $11.20M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.93M 10-Q · filed 2024-08-01 | $8.51M derived: sum of 3 quarters · filed 2025-02-25 | $11.21M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.66M 10-Q · filed 2024-04-30 | $5.24M derived: sum of 2 quarters · filed 2025-02-25 | $7.93M derived: sum of 3 quarters · filed 2025-02-25 | $10.47M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.27M derived: sum of 2 quarters · filed 2025-02-25 | $7.81M derived: sum of 3 quarters · filed 2025-02-25 | $10.39M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $5.24M derived: sum of 2 quarters · filed 2023-10-26 | $7.82M 10-Q · filed 2023-10-26 | $10.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $5.12M 10-Q · filed 2023-07-28 | $7.90M derived: sum of 3 quarters · filed 2024-02-28 | $10.77M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.58M 10-Q · filed 2023-04-28 | $5.36M derived: sum of 2 quarters · filed 2024-02-28 | $8.23M derived: sum of 3 quarters · filed 2024-02-28 | $11.23M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.64M derived: sum of 2 quarters · filed 2024-02-28 | $8.65M derived: sum of 3 quarters · filed 2024-02-28 | $11.72M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $5.87M derived: sum of 2 quarters · filed 2022-10-28 | $8.94M 10-Q · filed 2022-10-28 | $12.16M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $6.07M 10-Q · filed 2022-08-05 | $9.30M derived: sum of 3 quarters · filed 2023-02-24 | |
| 2021-03-31 | $3.07M 10-Q · filed 2022-05-06 | $6.29M derived: sum of 2 quarters · filed 2023-02-24 | ||
| 2020-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $12.75M 10-K · filed 2023-02-24 | ||
| 2020-09-30 | $9.52M 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $12.26M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |